Bulletin

Roche

Roche to present data at ASH 2022 showcasing strength of haematology portfolio and expanding into new areas to address more patient needs

November 3, 2022

Press Information Bureau

Department of Pharmaceuticals achieved the Set Targets during Special Drive on SCDPM 2.0

November 2, 2022

WHO

The European Commission and WHO extend their strategic cooperation to deliver better health for all

November 2, 2022

WHO

ACT-Accelerator Launches Six Month Plan As World Transitions To Long-Term Covid-19 Control

October 28, 2022

WHO

Tuberculosis deaths and disease increase during the COVID-19 pandemic

October 27, 2022

Roche

Roche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ECTRIMS 2022

October 26, 2022

WHO

Sraggering Backsliding Across Women's, Children's and Adolsent's health reveald in new UN analysis

October 18, 2022

ISPE

ISPE Provides Guidance on Improving and Advancing Process Performance and Product Quality Monitoring Systems

October 18, 2022

Roche

[Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022

October 18, 2022

WHO

Parliamentarians commit to support global health

October 18, 2022

WHO

Global leaders commit US$ 2.6 billion at World Health Summit to end polio

October 18, 2022

WHO

UNICEF and WHO welcome KSrelief funding for measles and polio epidemics prevention

October 17, 2022

Roche

Positive new data for Roche’s Evrysdi in largest trial ever undertaken in patients with previously-treated spinal muscular atrophy (SMA)

October 12, 2022

Roche

Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional use

October 12, 2022

Roche

Roche launches PRAME (EPR20330) Antibody to identify PRAME protein expression in patients that may have melanoma

October 11, 2022

WHO

Unique Friendship Benches initiative inaugurated to promote mental health, featuring competing FIFA World Cup nations

October 10, 2022

< 1 … 49 50 51 52 53 54 55 56 57 … 94 >

Bulletin

Roche to present data at ASH 2022 showcasing strength of haematology portfolio and expanding into new areas to address more patient needs

Department of Pharmaceuticals achieved the Set Targets during Special Drive on SCDPM 2.0

The European Commission and WHO extend their strategic cooperation to deliver better health for all

ACT-Accelerator Launches Six Month Plan As World Transitions To Long-Term Covid-19 Control

Tuberculosis deaths and disease increase during the COVID-19 pandemic

Roche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into neuromyelitis optica spectrum disorder at ECTRIMS 2022

Sraggering Backsliding Across Women's, Children's and Adolsent's health reveald in new UN analysis

ISPE Provides Guidance on Improving and Advancing Process Performance and Product Quality Monitoring Systems

[Ad hoc announcement pursuant to Art. 53 LR] Roche records solid results for the first nine months of 2022

Parliamentarians commit to support global health

Global leaders commit US$ 2.6 billion at World Health Summit to end polio

UNICEF and WHO welcome KSrelief funding for measles and polio epidemics prevention

Positive new data for Roche’s Evrysdi in largest trial ever undertaken in patients with previously-treated spinal muscular atrophy (SMA)

Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional use

Roche launches PRAME (EPR20330) Antibody to identify PRAME protein expression in patients that may have melanoma

Unique Friendship Benches initiative inaugurated to promote mental health, featuring competing FIFA World Cup nations

Company

Resources